Last reviewed: June 17, 2026
Last updated: June 17, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Yes, licensed physicians prescribe Wegovy (semaglutide) for chronic weight management when patients meet specific criteria. Wegovy received FDA approval in 2021 for individuals with a BMI of 27 or higher who have weight-related health conditions, or a BMI of 30 or higher regardless of comorbidities. PlexusDx provides access to compounded semaglutide injections through licensed 503A pharmacies, offering the same active ingredient at a lower monthly cost without insurance barriers.
How Doctors Determine Eligibility for Semaglutide Therapy
Prescribing physicians evaluate weight loss candidates using established medical guidelines and individual health history. Most doctors assess BMI, metabolic markers, previous weight loss attempts, and any weight-related conditions such as type 2 diabetes, hypertension, or sleep apnea. A thorough consultation helps determine whether semaglutide is medically appropriate for a specific patient profile.
Blood pressure, fasting glucose, and lipid panels provide doctors with baseline metabolic data before starting treatment. Physicians also discuss realistic weight loss expectations, typically 15-22% of body weight over 68 weeks based on clinical trial outcomes. This evidence-based approach ensures patients understand both the benefits and commitment required for sustained results.
The Clinical Mechanism Behind Semaglutide Weight Loss
Semaglutide works by activating GLP-1 receptors in the brain's appetite control centers, reducing hunger signals and increasing satiety. The medication slows gastric emptying, meaning food moves more gradually through the digestive system, keeping patients fuller longer. These dual mechanisms address the neurobiological drivers of weight gain rather than relying on willpower alone.
Clinical trials demonstrate that semaglutide produces sustained weight reduction by resetting how the brain perceives hunger and food reward. Patients typically experience reduced cravings, smaller meal portions, and less frequent snacking within the first two to four weeks of therapy. This physiological shift creates an environment where healthy eating patterns become easier to maintain.
Why Compounded Semaglutide Offers Doctor-Prescribed Weight Loss Access
PlexusDx partners with licensed 503A compounding pharmacies to provide physician-prescribed semaglutide injections at significantly lower costs than brand-name Wegovy. Compounded medications contain identical active pharmaceutical ingredients but bypass high brand markup, making treatment accessible to more patients regardless of insurance status. PlexusDx serves all 50 states with no membership fees and accepts HSA and FSA accounts for additional savings.
Doctors can prescribe PlexusDx compounded semaglutide using standard prescription protocols, with the medication shipped directly to patients' homes. The pricing structure remains flat at $149 per month across all dose levels, meaning dose adjustments never increase monthly costs. This transparent, predictable pricing allows physicians to recommend semaglutide for eligible patients without financial barriers preventing treatment initiation.
Personalized Semaglutide Response Through Genetic Testing
PlexusDx Precision Peptide Genetic Test identifies how individual genetic variants influence semaglutide response and weight loss outcomes. Testing examines key pathways including GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609—genetic markers that predict medication sensitivity and metabolic factors affecting weight. This peptide-pathway genetic analysis maps 14 biological pathways and 150+ personalized insights to optimize treatment selection.
Doctors increasingly use genetic testing to tailor weight loss therapy for individual patients, moving beyond one-size-fits-all approaches. PlexusDx offers this add-on test for $99 after the first month of treatment, allowing physicians to refine dosing strategy and predict long-term response based on each patient's unique genetic profile. This precision medicine approach improves outcomes and helps patients understand why specific treatments work better for their metabolism.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Will my doctor prescribe Wegovy or semaglutide if I have a BMI over 27?
Most doctors will consider semaglutide if your BMI exceeds 27 and you have weight-related health conditions, or if BMI is 30+ regardless of comorbidities. However, individual prescribing decisions depend on medical history, medication interactions, and physician judgment. PlexusDx allows you to work with a healthcare provider to explore compounded semaglutide eligibility starting at $149 per month.
How much weight do patients typically lose on semaglutide prescribed by doctors?
Clinical trials show patients lose an average of 15-22% of body weight over 68 weeks on semaglutide therapy. Results vary based on dose, lifestyle changes, genetic factors, and individual metabolism—some patients achieve greater reductions with consistent effort. PlexusDx Precision Peptide Genetic Test helps doctors predict your personal weight loss potential based on genetic markers.
Is PlexusDx semaglutide the same medication doctors prescribe as Wegovy?
Yes, PlexusDx offers compounded semaglutide from licensed 503A pharmacies containing the identical active ingredient as brand-name Wegovy. The difference is cost—PlexusDx pricing starts at $149 monthly with no insurance requirement, no membership fees, and HSA/FSA eligibility. Your dose may need to go up. Your price won't.
Are there safety concerns with doctor-prescribed semaglutide for weight loss?
Semaglutide is generally well-tolerated when prescribed appropriately by healthcare providers who monitor patient response. Common side effects include mild nausea, which typically decreases over time as the body adjusts. Doctors screen for contraindications such as personal or family history of medullary thyroid cancer before prescribing, ensuring safe treatment for eligible candidates.
How does PlexusDx genetic testing help my doctor prescribe better weight loss treatment?
PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R pathways that influence how your body responds to semaglutide and related therapies. This $99 add-on test provides doctors with 150+ personalized insights to optimize medication selection, predict response potential, and refine dosing strategy for maximum individual results.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Medications: Can You Take Ozempic with Losartan?
Why Did I Stop Losing Weight on Wegovy?